ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 135 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 135 | -32.5% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $2,000 | -71.4% | 200 | -37.5% | 0.00% | -66.7% |
| Q2 2021 | $7,000 | -22.2% | 320 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | +12.5% | 320 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | 0.0% | 320 | +45.5% | 0.00% | -25.0% |
| Q3 2020 | $8,000 | -20.0% | 220 | +29.4% | 0.00% | -20.0% |
| Q4 2019 | $10,000 | +150.0% | 170 | +70.0% | 0.01% | +150.0% |
| Q3 2019 | $4,000 | +33.3% | 100 | +42.9% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $3,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -25.0% | 70 | -12.5% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | +33.3% | 80 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,000 | -78.6% | 80 | -57.9% | 0.00% | -77.8% |
| Q1 2018 | $14,000 | +7.7% | 190 | 0.0% | 0.01% | +28.6% |
| Q4 2017 | $13,000 | -99.9% | 190 | -32.1% | 0.01% | -22.2% |
| Q3 2017 | $14,034,000 | +8.3% | 280 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $12,958,000 | +29.7% | 280 | 0.0% | 0.01% | +33.3% |
| Q1 2017 | $9,988,000 | – | 280 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |